VR Logo

Lupin Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1983

Chairman: Manju D Gupta

Managing Director: Nilesh Gupta

Group: Lupin

Listing: NSE: LUPIN, BSE: 500257

Headquarters: Mumbai, Maharashtra

Website: www.lupinworld.com

Key Facts

Market cap: R 46,195.24 Cr

Revenue (TTM): R 15,225.96 Cr

Earnings (TTM): R 1,152.70 Cr

Cash: R 4,792.55 Cr

Total Debt: R 6,305.32 Cr

Promoters' ownership: 46.88%

Liquidity: High

52 Week range: R 504.75 - 1,122.30

Face value: R2.00

Shares outstanding: 45,36,50,613

10 Years Aggregate:

  • CFO: 15,963.08 Cr
  • EBITDA: 27,984.10 Cr
  • Net Profit: 12,835.09 Cr

Stock Performance

Time Period Lupin S&P BSE Sensex S&P BSE Healthcare
YTD7.555.63-1.90
1 month-1.79-1.77-2.84
3 months10.7810.600.49
1 Year58.1434.0251.92
3 Years10.8314.7716.25
5 Years-10.3715.386.05
10 Years10.3810.5813.72
As on 08-Mar-2021
Year Lupin S&P BSE Sensex S&P BSE Healthcare
202026.6715.7561.45
2019-9.2714.38-3.55
2018-4.595.87-5.89
2017-40.4827.910.49
2016-19.421.95-12.88
201528.55-5.0315.06
201455.8029.8947.43